Chemotherapy increases survival and downstaging of upper tract urothelial cancer.

CONCLUSION: Neoadjuvant chemotherapy increases likelihood of downstaging to non-invasive disease in patients with upper tract urothelial cell carcinoma. Chemotherapy also provides an overall survival benefit in patients undergoing nephroureterectomy. PMID: 31629443 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31629443?dopt=Abstract

Source: Canadian Journal of Urology - October 21, 2019 Category: Urology & Nephrology Tags: Can J Urol Source Type: research